Sperm cell swimming through a blood vessel, cityscape in background

Leukemia's Hidden Impact: Unveiling Male Infertility Risks and Future Hopes

Jordan Keane in Health & Wellness November 2025 • 4 min read.

"New research sheds light on the connection between leukemia and male infertility, offering insights for patients and future fertility preservation."

Leukemia, a cancer affecting blood and bone marrow, is often associated with a range of well-known symptoms and treatments. However, emerging research suggests a less recognized impact: male infertility. While the primary focus remains on combating the disease itself, understanding its potential effects on reproductive health is crucial for comprehensive patient care.

Spermatogenesis, the complex process of sperm production, relies on a delicate balance of hormones and cell interactions within the testes. Leukemia and its treatments can disrupt this balance, potentially leading to reduced sperm count, motility issues, and other abnormalities. This can be particularly concerning for younger patients who may wish to have children in the future.

This article explores the intricate relationship between leukemia and male infertility, providing an overview of the current research, potential mechanisms, and strategies for preserving fertility. By understanding these connections, patients and healthcare providers can make informed decisions about treatment and family planning.

How Does Leukemia Impact Sperm Production?

Sperm cell swimming through a blood vessel, cityscape in background

Spermatogenesis, the creation of sperm, is a finely tuned process involving the proliferation and differentiation of spermatogonial stem cells (SSCs). These cells mature into sperm through various stages influenced by hormones and the testicular microenvironment. Leukemia can interfere with this process in several ways:

Hormonal Imbalances: Leukemia can disrupt the delicate endocrine system, affecting the production of key hormones like follicle-stimulating hormone (FSH), luteinizing hormone (LH), testosterone, and inhibin B. These hormones are essential for regulating SSC development and sperm maturation. Imbalances can lead to impaired sperm production.

Direct Infiltration: Leukemia cells can infiltrate the testes, potentially disrupting the normal cellular environment and affecting sperm production directly.
Cytokine Disruption: Leukemia can trigger the release of cytokines, signaling molecules that can disrupt the delicate balance needed for healthy spermatogenesis.
Systemic Inflammation: The disease can cause systemic inflammation, which may affect testicular function.
Treatment Side Effects: Chemotherapy and radiation, while crucial for treating leukemia, can also damage SSCs and impair sperm production.

Research indicates that leukemia patients often experience decreased semen parameters even before treatment begins, including reduced sperm count, motility, and morphology. These effects can persist even after treatment, highlighting the importance of proactive fertility preservation strategies.

Looking Ahead: Preserving Hope for the Future

While the impact of leukemia on male fertility presents significant challenges, ongoing research and proactive fertility preservation strategies offer hope for the future. Understanding the specific mechanisms by which leukemia affects spermatogenesis is crucial for developing targeted therapies and interventions. Options like sperm cryopreservation, testicular tissue cryopreservation, and hormonal therapies can help patients preserve their fertility and increase their chances of having children after treatment.

About this Article -

This article was crafted using a human-AI hybrid and collaborative approach. AI assisted our team with initial drafting, research insights, identifying key questions, and image generation. Our human editors guided topic selection, defined the angle, structured the content, ensured factual accuracy and relevance, refined the tone, and conducted thorough editing to deliver helpful, high-quality information.See our About page for more information.

Everything You Need To Know

How does leukemia affect a man's ability to have children?

Leukemia can impact sperm production through several mechanisms. It can cause hormonal imbalances by affecting key hormones like Follicle-Stimulating Hormone (FSH), Luteinizing Hormone (LH), Testosterone, and Inhibin B, which are crucial for sperm development. Leukemia cells can also directly infiltrate the testes, disrupting the cellular environment. Furthermore, the disease can trigger the release of cytokines and cause systemic inflammation, both of which can impair testicular function. Chemotherapy and radiation treatments for leukemia can also damage spermatogonial stem cells (SSCs), further hindering sperm production. The disruption of Spermatogenesis can be very damaging.

What is spermatogenesis and why is it important in the context of leukemia?

Spermatogenesis is the complex process of sperm production, involving the proliferation and differentiation of Spermatogonial Stem Cells (SSCs). It's important because it is essential for male fertility. If leukemia or its treatments disrupt spermatogenesis, it can lead to reduced sperm count, motility issues, and abnormalities in sperm morphology, potentially causing infertility. The impact on Spermatogenesis explains the importance of fertility preservation strategies for patients.

Why is it important to consider fertility preservation when someone is diagnosed with leukemia?

Fertility preservation is important because treatments for leukemia, such as chemotherapy and radiation, can damage Spermatogonial Stem Cells (SSCs) and impair sperm production. Also, Leukemia impacts key hormones such as Follicle-Stimulating Hormone (FSH), Luteinizing Hormone (LH), Testosterone, and Inhibin B. This can lead to infertility, especially in younger patients who may wish to have children in the future. Fertility preservation strategies, like sperm cryopreservation and testicular tissue cryopreservation, offer patients the opportunity to have biological children after completing their cancer treatment. In addition, there are hormonal therapies can help patients preserve their fertility and increase their chances of having children after treatment.

What are sperm cryopreservation and testicular tissue cryopreservation?

Sperm cryopreservation involves collecting and freezing sperm samples before leukemia treatment begins. This allows patients to store their sperm for potential use in assisted reproductive technologies like in vitro fertilization (IVF) at a later date. Testicular tissue cryopreservation is another option, particularly for patients who cannot produce sperm samples. It involves freezing a sample of testicular tissue containing Spermatogonial Stem Cells (SSCs) for potential future use. Hormonal therapies can help patients preserve their fertility and increase their chances of having children after treatment.

What are cytokines and how do they play a role in male infertility related to leukemia?

Cytokines are signaling molecules that can disrupt the delicate balance needed for healthy spermatogenesis. Leukemia can trigger the release of these Cytokines, which can interfere with the normal functioning of the testes and impair sperm production. This disruption is one of the mechanisms by which leukemia can negatively impact male fertility. Additionally, systemic inflammation caused by Leukemia will affect testicular function.